OBJECTIVE: Of the 34 million adult Americans (17%) using mind-body medicine therapies, 8 million (24%) have anxiety/depression. The evidence for using mind-body therapies to address varying depressive symptoms in populations with and without other chronic comorbidities is reviewed. METHODS: Systematic literature searches of PubMed (Medline), Embase, CINAHL, and the seven databases encompassed by Current Contents, Web of Science, and Web of Knowledge were conducted. Studies designed as prospective control-comparison, adult population, English, at least 2 weeks long, sample size >30, and with primary or secondary outcome as depression measured on an established scale were included. Methodologic quality was evaluated using the modified scale for assessing scientific quality of investigations (SASQI) for Complementary and Alternative Medicine (CAM). RESULTS: Ninety papers of about 2900 met both inclusion and exclusion criteria; 60% of them scored a SASQI >9 and were deemed of sufficient quality to be included in the review; 74% of these selected quality papers demonstrated positive effects on the improvement of depressive symptoms. All mind-body modalities included in the study had at least one positive study. For cancer patients, several studies noted the positive effects of yoga and combination therapies on depression severity. For both diagnosed depression and fibromyalgia, several studies noted the positive effects of mindfulness on depression severity. CONCLUSION: The use of evidence-based mind-body therapies can alleviate depression severity. They could be used with established psychiatric treatments of therapy and medications. The likely long-term increased cost-effectiveness of integrating these therapies deserves further investigation.
OBJECTIVE: Of the 34 million adult Americans (17%) using mind-body medicine therapies, 8 million (24%) have anxiety/depression. The evidence for using mind-body therapies to address varying depressive symptoms in populations with and without other chronic comorbidities is reviewed. METHODS: Systematic literature searches of PubMed (Medline), Embase, CINAHL, and the seven databases encompassed by Current Contents, Web of Science, and Web of Knowledge were conducted. Studies designed as prospective control-comparison, adult population, English, at least 2 weeks long, sample size >30, and with primary or secondary outcome as depression measured on an established scale were included. Methodologic quality was evaluated using the modified scale for assessing scientific quality of investigations (SASQI) for Complementary and Alternative Medicine (CAM). RESULTS: Ninety papers of about 2900 met both inclusion and exclusion criteria; 60% of them scored a SASQI >9 and were deemed of sufficient quality to be included in the review; 74% of these selected quality papers demonstrated positive effects on the improvement of depressive symptoms. All mind-body modalities included in the study had at least one positive study. For cancerpatients, several studies noted the positive effects of yoga and combination therapies on depression severity. For both diagnosed depression and fibromyalgia, several studies noted the positive effects of mindfulness on depression severity. CONCLUSION: The use of evidence-based mind-body therapies can alleviate depression severity. They could be used with established psychiatric treatments of therapy and medications. The likely long-term increased cost-effectiveness of integrating these therapies deserves further investigation.
Authors: Sarah M Corey; Elissa Epel; Michael Schembri; Sarah B Pawlowsky; Roger J Cole; Maria Rosario G Araneta; Elizabeth Barrett-Connor; Alka M Kanaya Journal: Psychoneuroendocrinology Date: 2014-07-21 Impact factor: 4.905
Authors: Herpreet Thind; Ryan Lantini; Brittany L Balletto; Marissa L Donahue; Elena Salmoirago-Blotcher; Beth C Bock; Lori A J Scott-Sheldon Journal: Prev Med Date: 2017-09-04 Impact factor: 4.018
Authors: P de Jonge; K J Wardenaar; H R Hoenders; S Evans-Lacko; V Kovess-Masfety; S Aguilar-Gaxiola; A Al-Hamzawi; J Alonso; L H Andrade; C Benjet; E J Bromet; R Bruffaerts; B Bunting; J M Caldas-de-Almeida; R V Dinolova; S Florescu; G de Girolamo; O Gureje; J M Haro; C Hu; Y Huang; E G Karam; G Karam; S Lee; J-P Lépine; D Levinson; V Makanjuola; F Navarro-Mateu; B-E Pennell; J Posada-Villa; K Scott; H Tachimori; D Williams; B Wojtyniak; R C Kessler; G Thornicroft Journal: Epidemiol Psychiatr Sci Date: 2017-12-28 Impact factor: 6.892
Authors: Rozita Jalilianhasanpour; Benjamin Williams; Isabelle Gilman; Matthew J Burke; Sean Glass; Gregory L Fricchione; Matcheri S Keshavan; W Curt LaFrance; David L Perez Journal: J Psychosom Res Date: 2018-02-13 Impact factor: 3.006
Authors: Paula Gardiner; Ekaterina Sadikova; Amanda C Filippelli; Suzanne Mitchell; Laura F White; Robert Saper; Ted J Kaptchuk; Brian W Jack; Lisa Fredman Journal: Complement Ther Med Date: 2015-03-20 Impact factor: 2.446
Authors: Felipe A Jain; Roger N Walsh; Stuart J Eisendrath; Scott Christensen; B Rael Cahn Journal: Psychosomatics Date: 2014-10-22 Impact factor: 2.386